ENDS Toxicity / Carcinogenic: Difference between revisions

no edit summary
No edit summary
No edit summary
Line 199: Line 199:
*[https://sci-hub.se/10.1016/j.yrtph.2016.10.003 PDF Version]
*[https://sci-hub.se/10.1016/j.yrtph.2016.10.003 PDF Version]
*Citation: Ana S. Cravo, Jim Bush, Girish Sharma, Rebecca Savioz, Claire Martin, Simon Craige, Tanvir Walele, A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks, Regulatory Toxicology and Pharmacology, Volume 81, Supplement 1, 2016, Pages S1-S14, ISSN 0273-2300, doi: 10.1016/j.yrtph.2016.10.003.
*Citation: Ana S. Cravo, Jim Bush, Girish Sharma, Rebecca Savioz, Claire Martin, Simon Craige, Tanvir Walele, A randomised, parallel group study to evaluate the safety profile of an electronic vapour product over 12 weeks, Regulatory Toxicology and Pharmacology, Volume 81, Supplement 1, 2016, Pages S1-S14, ISSN 0273-2300, doi: 10.1016/j.yrtph.2016.10.003.
*Acknowledgement: This work was funded and supported by Fontem Ventures B.V. Imperial Brands plc is the parent company of Fontem Ventures B.V., the manufacturer of the EVP prototype used in this study.


===2016 [https://academic.oup.com/ntr/article-abstract/19/2/160/2631650?redirectedFrom=fulltext Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study]=== <!--T:39-->
===2016 [https://academic.oup.com/ntr/article-abstract/19/2/160/2631650?redirectedFrom=fulltext Exposure to Nicotine and Selected Toxicants in Cigarette Smokers Who Switched to Electronic Cigarettes: A Longitudinal Within-Subjects Observational Study]=== <!--T:39-->